Navigating the Regulatory Maze: Telemedicine Compliance and Its Impact on Pharmacies and the Public Health
Live Webinar
1-2 PM CST | February 13, 2025
Credit: 1 contact hour | Topic Designator: 03 – Law
During the pandemic, telemedicine became the norm. With the arrival of GLP-1 agonists intended for weight loss, direct-to-consumer telemedicine is becoming increasingly popular. From a compliance perspective, however, not all telemedicine models are created equal.
This presentation will describe common compliance issues involving telemedicine that NABP has encountered through its accreditation programs, examine how these issues impact fulfillment pharmacies, and use prominent case studies to demonstrate the risks associated with non-compliant telemedicine models.
Please note that the webinar capacity is 1,000 participants; registration does not guarantee entry. Those who are unable to join the meeting may purchase the webinar recording that will be posted online when it becomes available.
Presenter
Justin Macy, PharmD, JD
Director of Innovation, National Association of Boards of Pharmacy
Justin specializes in the intersection of law, technology, and health care with a focus on pharmacy practice and drug regulation. Recently, Justin helped lead NABP’s Drug Supply Chain Security Act (DSCSA) efforts to support regulators, dispensers, and other trading partners by providing tools and education that enable implementation of DSCSA’s interoperability milestone (Pulse by NABP). Historically, Justin has worked closely with NABP’s Digital Health team. Prior to joining NABP, Justin was a specialist in Amazon’s Consumer Legal department and Associate Director of Innovation for a tech start-up.
